New Queen Mary School of Medicine, University of London Study Reveals Long Delays and Variability are Losing the UK Research and Jobs
University of London -- Significant new research from Warwick Business School and Queen Mary, University of London, warns that delays and variability in the approvals process for clinical research could be causing pharmaceutical companies to look outside the UK and risks the country losing some of its most experienced researchers.